U.S Stocks Turn Lower; Dow Tumbles Over 100 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday. The Dow traded down 0.44% to 30,639.41 while the NASDAQ fell 0.59% to 10,936.46. The SP also fell, dropping, 0.46% to 3,767.81. Also check this: RH, Walgreens And 3 Stocks To Watch Heading Into Thursday Leading and Lagging Sectors Utilities shares rose by 1.4% on Friday. Meanwhile, top gainers in the sector included American Water Works Company, Inc. (NYSE: AWK ), up 3% and Atlantica Sustainable Infrastructure plc (NASDAQ: AY ) up 3%. In trading on Friday, energy shares fell by 1.6%. Top Headline The ISM manufacturing index fell to 53 for June from 56.1 in May. Analysts, however, were expecting a reading of 54.9. Equities Trading UP VerifyMe, Inc. (NASDAQ: VRME ) shares shot up 21% to $2.3807 after the company announced liquidation of the G3 VRM Acquisition SPAC and initiated a new share repurchase program. Shares of Akebia Therapeutics, Inc. (NASDAQ: AKBA ) got a boost, shooting 18% to $0.4181 after the company executed an agreement to terminate its vadadustat Collaboration and License Agreements with Otsuka …
U.S Stocks Turn Lower; Dow Tumbles Over 100 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday. The Dow traded down 0.44% to 30,639.41 while the NASDAQ fell 0.59% to 10,936.46. The SP also fell, dropping, 0.46% to 3,767.81. Also check this: RH, Walgreens And 3 Stocks To Watch Heading Into Thursday Leading and Lagging Sectors Utilities shares rose by 1.4% on Friday. Meanwhile, top gainers in the sector included American Water Works Company, Inc. (NYSE: AWK ), up 3% and Atlantica Sustainable Infrastructure plc (NASDAQ: AY ) up 3%. In trading on Friday, energy shares fell by 1.6%. Top Headline The ISM manufacturing index fell to 53 for June from 56.1 in May. Analysts, however, were expecting a reading of 54.9. Equities Trading UP VerifyMe, Inc. (NASDAQ: VRME ) shares shot up 21% to $2.3807 after the company announced liquidation of the G3 VRM Acquisition SPAC and initiated a new share repurchase program. Shares of Akebia Therapeutics, Inc. (NASDAQ: AKBA ) got a boost, shooting 18% to $0.4181 after the company executed an agreement to terminate its vadadustat Collaboration and License Agreements with Otsuka …